SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-004349
Filing Date
2017-01-27
Accepted
2017-01-27 16:52:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v457734_sc13d-a.htm SC 13D/A 44150
  Complete submission text file 0001144204-17-004349.txt   45494
Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address
WEISS MICHAEL S (Filed by) CIK: 0001038977 (see all company filings)

Type: SC 13D/A

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Subject) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86661 | Film No.: 17554408
SIC: 2834 Pharmaceutical Preparations